Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.
about
FGF23 in Acute and Chronic IllnessCalcium and phosphate impact cardiovascular risk.Fibroblast Growth Factor-23-A Potential Uremic ToxinHigh-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.Effects of high doses of cholecalciferol in normal subjects: a randomized double-blinded, placebo-controlled trial.Nutritional vitamin D supplementation in dialysis: a randomized trial.Dose and time responses of vitamin D biomarkers to monthly vitamin D3 supplementation in overweight/obese African Americans with suboptimal vitamin d status: a placebo controlled randomized clinical trial.Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial.Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.Prevalence and predictors of vitamin D deficiency in healthy adults.Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children.Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.FGF23 Is Not Associated With Age-Related Changes in Phosphate, but Enhances Renal Calcium Reabsorption in Girls.Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial.Vitamin D and methylarginines in chronic kidney disease (CKD)Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial.Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia.Acute Homeostatic Changes Following Vitamin D2 Supplementation.
P2860
Q26778554-8AD80295-4880-40F5-AC59-E1A2E354F7CEQ27687570-B667AE6C-556E-423F-8EC6-BC634CCA6FAEQ28075648-55D12206-B85C-438E-8340-E9ED99984606Q30524139-45A1650F-5C42-429E-B130-1EF7003C6013Q34104962-28B52270-D6FD-42AD-A7F1-EB9325EE7997Q35278465-09C33863-2191-4FE8-AF00-19A1054A95A7Q35718737-A3E81301-401C-4DF6-A893-07188E0157ADQ35891498-3FC345C6-E6E8-4E00-A756-16272361A927Q36476324-CA9D0768-EC55-4DE1-98B8-764139223123Q37128249-9C853069-E11E-46AA-B642-F89D8E351C81Q37407740-A123E982-4C9C-4B6C-B4D5-60F975FF21D9Q38079128-106B0490-1E31-41A2-846E-A9838B481EDCQ38890172-78125AA9-1510-46A0-B030-8F81D6D4CF91Q41476606-C5925BC6-47F3-4D4A-BF0A-7BBD63C2C4F3Q42370194-8612451A-02E8-4D96-AD1C-4CEA99E0CFA7Q45934316-EFCC49AB-8A5C-4C1C-9EB6-FEAF12DD1C60Q47544778-97140787-1315-4623-A0C3-C8A8E656624AQ51199021-A8413FB3-E2D9-41DC-AC7E-7E32035163F2Q51308109-1D370F43-5A3F-4032-91B3-171BEBF54D93Q55417813-190CAE70-8B0C-47EA-9B96-7EF49BB1764C
P2860
Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Randomized trial assessing the ...... stration on circulating FGF23.
@ast
Randomized trial assessing the ...... stration on circulating FGF23.
@en
type
label
Randomized trial assessing the ...... stration on circulating FGF23.
@ast
Randomized trial assessing the ...... stration on circulating FGF23.
@en
prefLabel
Randomized trial assessing the ...... stration on circulating FGF23.
@ast
Randomized trial assessing the ...... stration on circulating FGF23.
@en
P2093
P2860
P356
P1476
Randomized trial assessing the ...... istration on circulating FGF23
@en
P2093
Benjamin Z Leder
Chantel M Baldwin
Douglas L Hayden
Joel S Finkelstein
Maria P Henao
P2860
P304
P356
10.2215/CJN.10030911
P577
2012-02-02T00:00:00Z